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A B S T R A C T  The mechanism of the anti-fl-adrenergic action of acetylcholine (ACh) 
on  Ca current,  /ca, was  examined using the  tight-seal, whole-cell voltage clamp 
technique in single atrial myocytes from the bullfrog. Both isoproterenol (ISO) and 
forskolin increased/ca dose dependently. After/ca had been enhanced maximally 
by ISO  (10 -8  M),  subsequent  application  of forskolin (50  #M)  did not  further 
increase/ca, suggesting that ISO and forskolin increase/ca via a common biochem- 
ical pathway, possibly by stimulation of adenylate cyclase. ACh (10 -s M) completely 
inhibited the effect of low doses of forskolin (2 x  10 -8 M), as well as ISO, but it 
failed to block the effects of high doses of forskolin (>5 x  10 -s M).  IntraceUular 
application of cyclic AMP (cAMP) also increased/ca. ACh (10 -s M) failed to inhibit 
this  cAMP  effect,  indicating  that  the  inhibitory action  of ACh  occurs at  a  site 
proximal to the production  of cAMP.  ACh  (10 -5 M)  also activated an inwardly 
rectifying K + current Irdxca). Intracellular application of a  nonhydrolyzable GTP 
analogue, GTP3,S (5 x  10 -4 M), activated Iro,  o0 within several minutes; subsequent 
application  of  ACh  (10 -5  M)  did  not  increase  Ira,  ca)  further.  These  results 
demonstrate  that  a  GTP-binding protein  coupled  to these  K §  channels  can be 
activated maximally by GTP~,S  even in the absence of ACh.  Intracellular applica- 
tion of GTP3'S also strongly inhibited the effect of ISO on/ca in the absence of 
ACh. Pertussis toxin (IAP) completely prevented both the inhibitory effect of ACh 
on/ca and the ACh-induced activation of Igtnca  ). GTP3,S  (50 ~zM-1 mM) alone did 
not  increase  /ca  significantly;  however,  when  ISO  was  applied  first,  GTP3'S 
(5 x  10 -4 M) gradually inhibited the ISO effect on/ca. These results indicate that 
ACh antagonizes the effect of ISO on/ca via a GTP-binding protein (G  i and/or Go). 
This effect may be mediated  through  a  direct inhibition by the cz-subunit  of G i 
which is coupled to the adenylate cyclase. 
INTRODUCTION 
In  the  heart  the  Ca current  (Ic~),  which  plays an  essential  role  in  generating  the 
action potential and controlling contractility, is regulated by autonomic transmitters 
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(Reuter,  1983;  Tsien,  1983;  Hartzell,  1988).  /3-Adrenergic  agonists  (e.g.,  ISO) 
increase/ca in both amphibian and mammalian myocardium. This effect is mediated 
by stimulation of adenylate cyclase (Fischmeister and Hartzell, 1986; Shibata et al., 
1986).  The  resulting  increase  in  intracellular  cAMP  activates  cAMP-dependent 
protein kinase and increases/ca by phosphorylation of either the Ca channel itself or 
a protein near the Ca channel (Bean et al., 1984; Brum et al., 1984; Kameyama et al., 
1985; Tsien et al., 1986). 
Hormonal  stimulation of adenylate cyclase requires  molecular interactions be- 
tween  at  least  three  separate  entities:  (a)  13-adrenergic  receptors,  (b)  a  guanine 
nucleotide regulatory protein (Gs), and (c) the catalytic subunit of adenylate cyclase 
(Rodbell, 1980; Gilman, 1984). Activation of 13-receptors  by a/3-agonist increases the 
rate of GDP release from, and GTP binding to Gs, which causes dissociation of G s 
into  a s-  and  /3y-subunits.  The  0q-subunit  combined with  GTP  then  activates  the 
catalytic site of adenylate cyclase (Northup et al., 1983a). G s can also be activated by 
nonhormonal substances such as cholera toxin and nonhydrolyzable GTP analogues 
(e.g., Gpp(NH)p, GTP~,S). Like ISO, these substances can also increase/ca (Pappano 
et al., 1982; Hescheler et al., 1986). 
In contrast to the apparently universal ability of 13-adrenergic  agonists to increase 
/ca, cholinergic agonists reduce/ca and consequently inhibit contractility of cardiac 
cells in different ways in amphibian and mammalian hearts. In mammalian ventricu- 
lar  cells ACh  by itself lacks  an  inhibitory effect on  either /ca  or  contractility; a 
significant inhibitory action of ACh  occurs only in  the  presence  of 13-adrenergic 
stimulation (Biegon and Pappano,  1980; Hescheler et al., 1986).  However, in chick 
ventricle (shortly after hatching) and frog myocardium ACh inhibits either/ca or 
contractility directly, i.e., even in the absence of 13-adrenergic  agonist (Antoni and 
Rotmann, 1968; Giles and Noble, 1976; Ten Eick et al., 1976; McAfee et al., 1978; 
Biegon and Pappano,  1980).  Interestingly, in mammalian ventricle  the inhibitory 
effect of ACh on/ca can be reversed by increasing concentrations of 13-adrenergic 
agonist (Hescheler et al., 1986), while in frog cells this effect has not been observed 
(Fischmeister and Shrier, 1988). 
A plausible mechanism for the muscarinic inhibition of/ca is that ACh can inhibit 
adenylate cyclase activity via activation of inhibitory GTP-binding proteins (G  i and/or 
Go). In mammalian and chick cardiac cells there is evidence for this scheme (Hazeki 
and Ui, 1981; Endoh et al.,  1985; Sorota et al., 1985; Hescheler et al., 1986). Two 
different possibilities have been suggested for the ACh-induced inhibition of adenyo 
late cyclase mediated via G i and/or Go: (a) The/~'y-subunits of G i and/or Go, which 
are  released  after stimulation of the muscarinic receptors  coupled  to  them,  may 
interact with free as-subunits from the stimulatory G s protein to promote formation 
of an inactive G s oligomer. This represents  an indirect inhibition (Northup  et al., 
1983b;  Katada et al., 1984a).  (b) a i but not a o may compete with ct  s for the same site 
on the adenylate cyclase (Katada et al.,  1986).  This effect has been referred to as 
direct inhibition. At present it is unclear which of these mechanisms may be involved 
in mediating the inhibitory effect of ACh on adenylate cyclase in vivo. 
Other  possible  mechanisms  for  the  muscarinic  effects  on  /ca  must  also  be 
considered.  ACh  may reduce  cAMP  levels  by,  for  example,  the  activation  of a 
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has  been  suggested  that  ACh  may stimulate  a  protein  phosphatase  or  a  protein 
kinase, e.g., protein kinase C  (Watanabe et al.,  1984; Shibata et al.,  1986; Lacerda et 
al.,  1988). 
We have attempted to clarify the mechanism(s) of ACh-induced inhibition of/ca by 
applying tight-seal voltage clamp techniques  (Hamill  et al.,  1981; Hume and Giles, 
1983) to single atrial myocytes from the bullfrog. Our results show that in frog atrial 
cells the activation of Gi and/or G O  by a muscarinic agonist (ACh) interferes with the 
signal  transduction  process from/3-adrenergic  receptor to Ca channel,  and suggest 
that the inhibitory action of ACh on/ca is caused by the direct inhibitory effect on 
adenylate cyclase. 
METHODS 
Preparation 
Single  cells  were  isolated  from  bullfrog  atrium  using  methods  very  similar  to  the  ones 
described  previously  by  Hume  and  Giles  (1981)  and  Giles  and  Shibata  (1985).  Recent 
modifications will be described briefly. Adult bullfrogs, Rana catesbeiana, were killed and the 
atrium was removed and cut into  1-mm x  1-nun pieces in a Ca-free Ringer's solution (see 
below). These muscle segments were then treated with two enzyme-containing solutions: First, 
they were  transferred  into  5  ml  of Ca~+-free  Ringer's  solution  containing  240  IU/ml  of 
collagenase (Yakult  Co. Ltd., Tokyo, Japan) together with 3,600 IU/ml of acetylated bovine 
pancreatic  trypsin  (type III; Sigma Chemical  Co.,  St.  Louis,  MO)  and  incubated  at  room 
temperature (22-24~  for 45 rain. This enzyme-containing solution was then pipetted offand 
the atrial  tissue segments were washed, first in Ca2+-free Ringer's solution containing 0.1% 
bovine albumin  (Sigma Chemical  Co.)  and  then  in  Ca~+-free  Ringer's solution.  Next,  the 
pieces  of atrium  were  reincubated  in  5  ml of Ca2+-free Ringer's solution containing  120 
IU/ml of the Yakult collagenase for an additional  45--60 rain.  In the final step,  the tissue 
segments  were  collected,  resuspended  in  Ca2+-free  Ringer's  solution,  and  then  gently 
triturated (five times) using a large bore (2 mm in diameter) Pasteur pipette. This yielded an 
acceptable number of viable single cells. An aliquot of this cell suspension was transferred into 
the recording chamber, which contained HEPES-buffered Ringer's solution. 
In experiments  involving pretreatment  with  pertussis  toxin  (IAP) the isolated atrial  cells 
were divided into two groups and incubated for 6 h at 30~  in normal Ringer's solution either 
with or without IAP (500  ng/mi) by placing culture dishes  of these cell  suspensions in an 
incubator under a humidified atmosphere of 95% air to 5% CO  2. 
Solutions  and Drugs 
The composition of the superfusing solutions (in raM) was as follows.  Normal Ringer's: NaCI 
90, NaHCO  s 20, KC12.5, MgCI  2 5.0, CaC12 2.5, glucose 8, saturated with 95% 02 and 5% CO  2 
(pH 7.4).  HEPES Ringer's: NaCI 110,  KC1 2.5, MgCI  2 5.0, CaC12 2.5, glucose 5, HEPES 5, 
buffered with NaOH to pH 7.4. Ca-free Ringer's: the same as the HEPES Ringer's solution 
except that CaClz was added to a final concentration of 8  x  10 -6 M. Recording microelec- 
trodes were filled with a solution of the following composition (in mM): K-aspartate 90, KC1 
20, EGTA-KOH 0.77, Na~-ATP 3, MgCI  2 1, HEPES 5, buffered to pH 7.3 with KOH. 
The drugs used in these exeriments  were ISO, ACh, forskolin, atropine,  adenosine-3':5'- 
cyclic monophosphate (cAMP),  propranolol, and IAP (Sigma Chemical Co.), and guanosine- 
5'-O-3-thiotriphosphate  (GTP~'S;  Boehringer  Mannheim,  Biochemicals,  Indianapolis,  IN). 
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In each experiment, just before use,  the stock solution of the drug was diluted in HEPES 
Ringer's to the desired concentration. All experiments were performed at room temperatures 
(22-24~ 
Recording Technique 
The gigaseal patch clamp technique was used in the whole-cell configuration (Hamill et al., 
1981; Hume and Giles,  1983). The details of electronic circuits used for suction microelec- 
trode voltage clamp have been described previously (Giles and Shibata, 1985; Clark and Giles, 
1987).  To prepare  the suction microelectrodes,  square  bore borosilicate  tubing (1  mm in 
diameter; Glass  Co. of America, Bargaintown, N  J) was heated and pulled by gravity using a 
vertical micropipette puller (700D; David Kopf Instruments, New Haven, CT). The tips of the 
resulting  micropipettes  were  smooth enough  to make  a  gigaohrn seal without  being fire- 
polished.  Their  DC  resistances  varied  between  3  and  6  Mfl  when  filled  with  the  pipette 
solution. Under the whole-cell clamp conditions series resistances varied between 3 and 8 Mfl. 
This was electronically compensated  to  1-6  Mft.  A  hydraulic  micromanipulator  (MO-102; 
Narishige Scientific Instruments, Tokyo, Japan) which was mounted on the fixed stage of an 
inverted microscope (Nikon Diavert) was used to position the microelectrode near the cell. 
The seal resistance formed between electrode tip and cell membrane was between 5 and 30 
Gfl. Membrane potential (V~) was measured with a high input impedance unity gain amplifier 
(model 1600; A-M Systems Inc., Everett, WA). To measure current in the voltage clamp mode, 
a custom-designed circuit (Clark and Giles,  1987) was used in a current-to-voltage converter 
configuration. Transmembrane currents were measured as the voltage drop across a 100-Mfl 
feedback resistor. 
Data Storage and Analysis 
Membrane  potential  and current signals were monitored on a  storage oscilloscope (model 
5516ST, Kikusui, Tokyo, Japan) and stored in a microcomputer (IBM-AT) using an analogue- 
to-digital conversion board (Data Translation DT 2801-A) controlled by our acquisition and 
display software (Robinson and Giles,  1986). These records were also stored on video tape 
using an adaptor circuit for a digital VCR instrumentation recorder (model PCM-1; Medical 
System Corp., Great Neck, NY). The frequency-response of this device was DC-20 kHz. After 
the experiment,  the stored data were  sent  to a  DEC VAX  11-750  computer for analysis, 
graphing, and archiving. 
RESULTS 
ACh-induced Inhibition of Isoproterenol Effects on Ic~ 
Fig.  1  shows the effect of a/3-adrenergic  agonist,  ISO on/Ca.  The cell was held at 
-40  mV to inactivate the Na current, and voltage clamp pulses were applied at 0.2 
Hz.  As  shown  previously  (Giles  et  al.,  1989),  in  control  conditions  positive  to 
approximately  -  30 mV, a q-TX-resistant transient inward current,/ca, can be elicited 
(Fig.  1 A).  This  is  followed by slower  activation  of an  outward  current,  IK.  Upon 
repolarization  to  the  holding  potential,  tail  currents  due  to  I K deactivation  are 
recorded. An inwardly rectifying background current, IK,, was elicited by hyperpolar- 
izing pulses. 
ISO (10 -6 M) increased both/ca and I~. Both of these effects of ISO were blocked 
by the 0-antagonist propranolol (3 x  10 -7 M; not shown), indicating that/3-adrener- 
gic receptors mediate these current changes (Giles et al.,  1989).  In the presence of NAKAJIMA  ET AL.  Acetylcholine Inhibits Ic, in Bullfrog Atrium  869 
10 -6 M  ISO, the peak inward lea (measured from the zero current level) increased 
from -110  _+  42.0 to  -1,034  +  380 pA (n =  10) at 0  mV (Fig.  1B). The effect of 
ISO on lea was maximal at concentrations greater than 10 -6 M. 
The data in Fig. 2  show (a) the time-course of the ISO-induced stimulation of lea 
and  (b)  the  inhibitory  action  of ACh  (10 -5  M)  on  lea.  This  cell  was  held  at  a 
membrane potential of -40  mV and depolarizing pulses to 0 mV were applied at 0.2 
Hz.  Superimposed Ic~ records  are  shown  in  Fig.  2 A.  Fig.  2 B  illustrates  the  time 
course  of the  changes  in  /ca  and  the  holding  current,  measured  from  the  zero 
current level (+ and D, respectively). ISO (10 -6 M) increased lea from -80  to -850 
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The  effect of ISO on  calcium currents  in  single  atrial  cells.  The  membrane 
potential was held at -40 mV and 1.5-s pulses were applied to various membrane potentials at 
0.2 Hz in 10-mV increments. A shows the original current traces before (O) and after (Q) the 
application of ISO (10 -6 M). The zero current level is shown by the triangle.  These effects on 
the peak (O, 0) and the isochronal I-V relationships (at the end of the 1,500-ms pulse (D, I) 
are illustrated in B. The I-V relationship after ISO is shown by solid symbols. 
pA without a  significant change in the holding current.  Subsequent  application of 
ACh (10 -s M) shifted the holding current in the outward direction by ~ 100 pA. This 
current,  IK(AC~), has  been  described  previously in  atrial  myocytes (Momose  et  al., 
1984;  Soejima and Noma,  1984;  Kurachi et al.,  1986b; and Simmons and Hartzell, 
1987; Clark et al.,  1990).  When ACh was applied, lea decreased rapidly at first and 
then more slowly (Fig. 2 B). After several minutes lea reached a steady-state level well 
below the control. Subsequent application of a muscarinic antagonist (atropine, 10 -6 
M) quickly blocked both IK(ACh)  and the inhibitory effect of ACh on lea. However, the 
inhibitory effect of ACh on lea could not be completely reversed by atropine. This 870  THE JOURNAL  OF  GENERAL  PHYSIOLOGY ￿9 VOLUME  96 ￿9 1990 
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FIGURE  2.  Inhibitory effect of ACh on  ISO-induced increase in/ca.  In this  and  following 
figures, the membrane potential was held at  -40  mV and a 200-ms depolarization pulse to 0 
mV was applied at 0.2  Hz. The current  traces illustrated in A  were recorded in control  (a), 
10 -6 M ISO (b), 10 -6 M ISO plus 10 -s M ACh (c), and 10 -6 M ISO plus 10 -s M ACh plus 10 -6 
atropine (d). The current traces (a-d) were recorded at the times indicated by these letters in 
B.  In this and subsequent figures the protocol (drug sequence) is shown in the upper part of 
B,  and  the lower part  of B  shows  the  time course  of changes  in the peak  /ca  (+)  and  the 
holding current (17) measured from the zero current level. Note that ACh (10 -5 M) shifted the 
holding current (and hence the peak of/ca) in the outward direction by ~100 pA, indicating 
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may be due to run-down of/ca or desensitization of isoproterenol response. When 
both ACh (10 -5 M) and atropine (10 -s M) were applied simultaneously, the effect of 
ACh  on  /ca  was  completely abolished.  These  results  indicate  that  the  inhibitory 
effects of ACh on IK~,~  ) and/Ca are mediated by muscarinic receptors. Additional 
experiments demonstrated that 10 -s M ACh completely inhibited the effects of ISO, 
even when 10-5 M ISO was applied (n =  3). In contrast to this finding, Hescheler et 
al. (1986) have reported previously that the inhibitory effect of ACh on/ca in guinea 
pig ventricle can be overcome by increasing the concentration of ISO (see Discus- 
sion). 
Effect of ACh on Ic~ in the Presence of cAMP 
To determine whether the intracellular biochemical reactions corresponding to this 
ACh  effect occur proximal  or distal  to  the  catalytic actions  of adenylate  cyclase, 
intracellular cAMP was increased by adding cAMP (10 -4 M) to the recording pipette 
(Fig.  3).  Ic~  increased  progressively as  cytosolic cAMP  was  increased  via dialysis. 
Subsequent application of ACh (10 -s M) failed to significantly inhibit this increase in 
/ca. The activation of I~ACh  ) caused an apparent outward shift in the peak of/ca of 
-80 pA.  8  Atropine (10-  M) completely inhibited the effect of ACh on IV~ACh), and the 
baseline  4  of/ca also shifted back to the inward direction. CdCI~  (5 x  10-  M), a  Ca 
channel  blocker,  completely  blocked  cAMP-enhanced  /ca.  Similar  results  were 
observed in experiments using 10-fold lower (10 -5 M) cAMP concentrations in the 
pipette (n =  2). These results provide strong evidence that the effect of ACh on/ca is 
not mediated by the mechanism distal to the catalytic actions of adenylate cyclase, in 
contrast to a preliminary report by Shibata et al. (1986). 
Effect of Forskolin on Ic, 
Forskolin is known to stimulate adenylate cyclase (Seamon and Daly,  1986) and to 
increase  /Ca  (Hescheler  et  al.,  1986;  Hartzell  and  Fischmeister,  1987).  To  test 
whether the  ISO and  forskolin effects on /ca are additive,  maximal doses of ISO 
(2 x  10 -6  M)  and  forskolin (5 x  10 -5  M) were applied  (Fig.  4).  ISO dramatically 
increased/ca, but the subsequent application of forskolin failed to increase/ca any 
further. Thus, the effects of these two agents on/ca are not additive. The observed 
saturation of the ISO and forskolin actions suggests that the forskolin effect on/ca in 
frog  heart  is  mediated  by  the  adenylate  cyclase  cascade.  This  probably  occurs 
through a direct activation of the catalytic subunit of adenylate cyclase, as is the case 
in other cell types (Hescheler et al., 1986; Hartzell and Fischmeister, 1987). 
ACh-induced Inhibition of Forskolin Effects on Ic~ 
Low doses of forskolin (2 x  10 -6 M)  gradually increased/ca (Fig.  5).  Addition of 
ACh  (10 -s  M)  after forskolin  treatment  completely blocked the  forskolin  effect. 
Atropine (1  #M) reversed this effect of ACh on/ca. However, when higher doses of 
forskolin were applied,  the inhibitory action of ACh was overcome. In the experi- 
ment shown in Fig. 6, ACh (10 -s M) completely inhibited the effect of ISO (10 -8 M) 
on/ca, but subsequent application of forskolin (5.0 x  10 -5 M) significantly increased 
/ca. Atropine (1 #M) completely blocked the effect of ACh on IKO,~), which caused an 
apparent shift in the peak of/ca in the inward direction (by ~ 100 pA). However,/Ca 872  THE JOURNAL OF GENERAL  PHYSIOLOGY  ￿9  VOLUME 96 ￿9 1990 
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FIGURE 3.  Effect of ACh on/ca after intracellular application of cAMP. cAMP (10 -4 M) was 
applied by dialysis  through the recording micropipette. The current traces in A labeled a-d 
were recorded at the times indicated by these letters in B. Control (a) and after the application 
of (10 -5 M) ACh (b), 10 -s M ACh plus 10 -6 M atropine (c), and these drugs plus Cd  2+ (0.5 
raM)  (d)  are  shown.  Note that ACh did not have an  inhibitory effect on /ca under  these 
conditions. 
itself was not increased by atropine.  These results indicate  that Ic~ can be activated 
maximally  by  forskolin  (5 x  10 -5  M)  even  after  the  application  of ACh.  Similar 
findings were obtained when ACh (10 -5 M) was applied in the absence of ISO; i.e., 
ACh  (10 -5  M)  had  no  significant  effect  on  /Ca  in  the  presence  of high  doses  of 
forskolin  (>5  x  10 -5  M),  showing  that  maximal  (saturating)  concentrations  of 
forskolin  can  overcome the  effect of ACh on/ca.  CdC12  (5 x  10 -4  M)  completely 
blocked the forskolin-induced enhancement of/ca. These results indicate that in frog NAKAJIMA ET AL.  Acelylcholine Inhibits Ic~ in Bullfrog Atrium  873 
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FIGURE 4.  Saturation of the stimulatory effects  of ISO and forskolin on/ca. The current 
traces shown in A were recorded in control (a), after 2  x  10 -6 M ISO (b), and after 2  x  10 -6 
M ISO plus 5  x  10 -s M forskolin (c). The current traces in A (a-c) were recorded at the times 
indicated by these letters in B. 874 
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FIGURE 5.  The effect of ACh on forskolin-enhanced Ic~. The current traces shown in A were 
recorded in control (a), in 2  x  10 -6 M forskolin (b), in forskolin (2 x  10 -6 M) plus ACh (10 -5 
M) (c), and in forskolin (2 x  10 -6 M) plus ACh (10 -5 M) plus atropine (10 -6 M) (d) at the times 
indicated by the corresponding letters in the graph in B. 
atrial cells inhibitory muscarinic effects of ACh on Ic~ can override the stimulatory 
effects of ISO, and that the site of the action of ACh may be the same as the site for 
forskolin  stimulation  of  Ic~,  i.e.,  the  catalytic  subunit  of  adenylate  cyclase  (see 
Discussion). 
Involvement of GTP-binding Proteins in ACh Effects 
To  study  whether  the  effect  of ACh  on  Ic~  involves  activation  of  the  inhibitory 
GTP-binding  proteins  (G  i  and/or  Go),  atrial  cells  were  pretreated  with  IAP,  an NAKAJIMA  ET AL.  Acetylcholine Inhibits Ic~ in Bullfrog Atrium  875 
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islet-activating protein from the bacterium Bordetella  pertussis.  In IAP-treated cells 
(n =  3; Fig. 7), application of ISO (10 -6 M) significantly increased/ca (150 _+ 20 pA 
in control to  1,350 _+ 200 pA, n  =  3) even in the presence of ACh (10 -s M). The 
effect of ACh on IK~,Ca) was also abolished after IAP treatment. Atropine (10 -6 M) 
failed to further increase/ca, indicating that IAP completely removed the effect of 
ACh  on /ca.  These results  indicate  that  the  GTP-binding proteins  that  are ADP- 
ribosylated by IAP mediate the effects of ACh on/ca and IK~xCh). An earlier abstract 
from our laboratory (Shibata et al., 1986) reported that IAP treatment did not block 
the activation of IK~,~). These incorrect findings appear to have resulted from the 
exposure time to IAP, which was too short at room temperature. 
To obtain further insight into the molecular mechanisms of these ACh effects, a 
nonhydrolyzable GTP analogue, GTP3,S, was dialyzed into the cell from the record- 
ing pipette (Fig. 8). GTP3,S (5 ￿  10 -4 M) activated IK~,C~) gradually, as indicated by 
the slow increase in the holding current in the outward direction. In addition, the 
application of GTP3,S almost completely inhibited the effect of ISO (10 -6 M) on/ca 
even in  the absence of ACh.  However, /ca could still  be increased by subsequent 
application of forskolin (5 x  10 -s M). These results and the data in Fig. 6 show (a) 
that forskolin (50 #M) can overcome the inhibitory effects of either ACh or GTP3,S 
on/ca, and (b) that GTP3,S can activate the G i and/or G O protein directly, i.e., even 
without an agonist being present. After the effects of GTP'yS were fully developed, 
subsequent application of ACh did not activate IK~,Ca) any further, indicating that the 
G i  and/or  G O proteins  were  maximally  activated  by  this  GTP3'S  concentration 
(5 x  10 -4  M).  These  results  also  suggest  that  in  bullfrog  atrial  cells,  maximum 
activation of G i and/or G O  proteins can overcome the effects of activation of G s. 
GTP3,S was also dialyzed into IAP-treated atrial cells. Application of GTP3,S (500 
/~M) activated I~aACh) and also inhibited the effect of ISO (10 -6 M) on/Ca (not shown, 
n  =  3),  which  suggests  that  IAP  blocks  the  coupling  between  the  muscarinic 
receptors and GTP-binding proteins, but that it does not affect the coupling between 
G  proteins and adenylate cyclase or Iv~^~  ). In summary, our results are consistent 
with a molecular pharmacological scheme in which ACh exerts its inhibition effect on 
adenylate  cyclase via  the  activation  of G i  and/or  G O proteins.  The  ACh-induced 
effect, mediated by G i and/or G o, can override that of the stimulatory G protein (Gs) 
effect. In contrast, activation of the catalytic subunit of adenylate cyclase by forskolin 
can overcome the inhibitory effects of even maximal doses of ACh. 
DISCUSSION 
Summary of Findings 
These experiments have confirmed that  in  frog atrium ACh  activates an inwardly 
rectifying  K +  current,  IK~C~), and  that  this  effect is  mediated  by  the  inhibitory 
GTP-binding protein(s) (Gi and/or Go), which can be ADP-ribosylated by IAP and 
thus  uncoupled  from  the  muscarinic  receptor  (cf.  Clark  et  al.,  1990).  ACh  can 
antagonize the stimulatory effects of/3-adrenergic agonists on/Ca. This effect is also 
mediated via G i and/or G o. The effects of G i and/or G O  appear to be able to override 
those of the stimulatory G  protein (G,) on adenylate cyclase activity, since ACh can 
almost completely inhibit the effect of 13-adrenergic agonists on/ca. 878  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  96  ￿9  1990 
A 
El.  :  " 
fc 
100  ms 
nA 
B  ISO  1 pM 
I  Forskolin  50 pM 
ACh ] 10 pM 
I 
0.2 
0 
A 
< 
e- 
e" 
L_ 
t,. 
O 
-0.5 
b 
I  I 
8 
+ 
+ 
+ 
+ 
'  46o 
Time  (s) 
+ 
+ 
t 
§  d 
+t%~+.-~-~  c .~ 
i  E  i 
800 
FIGURE 8.  Effect of a  nonhydrolyzable GTP analogue (GTP3'S) on the ISO- and forskolin- 
induced  increase  in /ca.  GTP3,S  (500  pM)  was  applied  by dialysis through  the  recording 
electrode. The current trace (a) was recorded immediately after impalement of the cell. After 
GTP3"S  had diffused into the cell IKt^Ch~ ([3)  gradually increased. Subsequent application of 
10 -6 M ISO (b) failed to increase/ca significandy, but 5  x  10 -5 M forskolin still augmented/ca 
(c). However, the subsequent application of 10 -5 M ACh (d) did not increase IK(ACh)  any further 
and also failed to block the effect of forskolin on/ca. The current traces  shown in A  were 
recorded at the times indicated by the corresponding letters in B. NAKAJIMA  El" AL.  Acetylcholine  Inhibits Ic~ in Bullfrog Atrium  879 
Direct Inhibition of Adenylate Cyclase by ACh 
A  direct inhibitory action of the dissociated subunit of a  G  protein (probably the 
ai-subunit) on the catalytic activity of the adenylate cyclase, appears to be involved in 
the  inhibitory effect of ACh  on /Ca. Several  possible  mechanisms  for the  G i-  or 
Go-mediated inhibitory effects of ACh on adenylate cyclase have been proposed. One 
possibility is that the/3T-subunit that is released from Gi and/or G  O  after stimulation 
of muscarinic receptors may interact indirectly with free a,-subunit of G, to promote 
formation of an inactive G s oligomer. Alternatively, a i may compete directly with G, 
for the same locus on the catalytic site of adenylate cyclase (Katada et al.,  1984, 
1986). It is still not clear whether the effect of ACh on adenylate cyclase is mediated 
by the direct inhibition of its catalytic subunit (C), whether it is mediated indirectly 
via changes in the efficacy of Gs-C interaction, or whether a  combination of both 
mechanisms is involved (Gilman, 1984;  Katada et al.,  1986; Birnbaumer,  1987).  In 
frog atrial  cells our results  favor the direct  mechanism.  If the indirect action of 
/~-subunit was predominant, the activation of G, by GTP3,S  would be expected to 
irreversibly stimulate the adenylate cyclase and increase/ca even after activation of Gi 
and/or G O  by ACh or GTPTS, since the/3T-subunit could not associate with a,, which 
would be bound to GTPTS (Fleming and Watabe, 1988). However, as shown in Fig. 
8, in frog atrial cells GPTTS (50 #M-1 raM) by itself activated IK~ACa),  but/Ca was not 
increased significantly. Moreover, when GTPTS (500 #M) was applied after pretreat- 
ment with ISO (10 -6 M) to activate G s (Schramm and Rodbell, 1975) (Fig. 9),/Ca was 
first  increased  (by  ISO),  but  as  cytosolic  GTP'yS  levels  increased  /ca  gradually 
decreased, and IKtACh) was also activated. Thus, we conclude that in frog atrial cells 
ACh inhibits the effect of/3-adrenergic agonists, mainly by a  direct action of the 
a-subunit of G i on adenylate cyclase. This direct action of ACh on adenylate cyclase 
can also inhibit the effect of forskolin. 
Activation of Ix~acn) by the Nonhydrolyzable GTP Analogue,  GTPTS 
ACh activates a specific inwardly rectifying K + channel in frog atrial cells (Momose et 
al.,  1984; Breitwieser and Szabo,  1985;  Simmons and Hartzell,  1987;  Clark et al., 
1990) and in mammalian atrial cells (Soejima and Noma, 1984; Kurachi et al., 1986a, 
b).  Recent  studies  on  mammalian  atrial  cells  have  shown  that  the  GTP-binding 
proteins are essential for the activation of these K + channels by muscarinic agonists. 
The  following findings support  this hypothesis. When  nonhydrolyzable GTP ana- 
logues  (e.g.,  GTP"t'S,  Gpp(NH)p)  are  applied,  a  persistent  activation of IK~^Ch) is 
observed  (Kurachi et al.,  1986b;  Breitwieser and Szabo,  1985).  IAP,  which ADP- 
ribosylates the G proteins (G  i and/or Go) (Katada and Ui, 1982; Ui, 1984), eliminates 
this activation of the K + channel by ACh  (Pfaffinger et al.,  1985;  Kurachi et al., 
1986b).  Recent demonstrations that the bath applications of the/3-r-subunit of Gi 
and/or G O can  activate IK~ACh) (Logothetis et al.,  1987;  Yanati et al.,  1987a)  may 
provide further insight into the mechanism(s) of activation of this K + current by 
ACh. 
Pfaffinger et  al,  (1985)  and  Breitwieser and  Szabo  (1985)  have  shown  that  G 
proteins are involved in the activation of IraACh). Our results confirm these findings. 
The  application of the nonhydrolyzable GTP  analogue  (GTPTS)  consistently acti- 
vated Iv~ch), and IAP abolished the effect of ACh-induced K + current. This result is 880  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY ￿9 VOLUME  96  ￿9  1990 
somewhat different from those of Breitwieser and Szabo (1985) and Simmons and 
HartzeU (1987). In both of these studies a different nonhydrolyzable GTP analogue 
(Gpp(NH)p) failed to activate IKtACh) in the absence of ACh.  It is possible that this 
difference can be explained by the choice of GTP analogues and/or their concentra- 
tions.  The  failure of Gpp(NH)p  to  activate IraxCh) may indicate  that  the  ratio  of 
Gpp(NH)p/GTP  in  their  preparations  was  too  low  to  allow  significant  agonist- 
independent activation, since  they used low pipette concentrations of Gpp(NH)p, 
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GTP3,S (500 ~tM) was applied by dialysis through the recording micropipette. Current traces 
taken at the times indicated by the letters (a-c) are superimposed in the inset of the lower 
panel. Note that after application of ISO (10 -6 M) Ic~ first increased (b), but then gradually 
decreased (c) as GTP3,S diffused into the cell Ig4ACh  ) also increased (b-c) as GTP3,S diffused into 
the cell. 
and  did not  "clamp"  the GTP concentration (Breitwieser and  Szabo,  1988).  Our 
results  show  that  GTP~tS  (500  gM)  can  consistently activate  IV~ACh) even  in  the 
absence  of ACh,  and  that  this  effect reaches  a  steady-state  level  within  several 
minutes. Subsequent application of ACh did not further increase IK~ACh), indicating 
that  the  GTP-binding  protein  coupled  to  IK(ACh) was  activated  maximally  by  the 
(GTPTS).  In  addition,  our  results  confirm  that  IAP  selectively uncouples  the  G 
protein(s) from the muscarinic receptor (Cote et al.,  1984; Logothetis et al.,  1987), NAKAJIMA  El" AL.  Acetylcholine  Inhibits Ic~ in Bullfrog Atrium  881 
because even in IAP-treated cells the application of GTP3,S  could activate IK(ACh) in 
the absence of ACh. 
Muscarinic Inhibition of Ica 
In frog atrial and ventricular cells in normal Ringer's only a single type of Ca current 
can be detected. It is sensitive to dihydropyridines and resembles L type Ca current 
in  other  preparations,  including mammalian cardiac  cells  (Argibay et  al.,  1988; 
Campbell et al., 1988). 
It is now well known that in frog and mammalian myocardial cells ACh can inhibit 
Ic~ in the presence of/3-adrenergic agonists (Breitwieser and Szabo, 1985; Fischmeis- 
ter and Hartzell, 1986; Shibata et al., 1986).  In frog atrium ACh appears to inhibit 
the action of/3-adrenergic agonists in a noncompetitive manner, since ACh (10 -5 M) 
almost completely inhibited the ISO-induced increase in/ca, even in the presence of 
saturating concentrations of ISO (>_10  -8 M), consistent with the findings of Fisch- 
meister and  Shrier  (1989)  in  frog ventricular  cells.  We  attempted  to  determine 
whether the mechanism of this inhibition is different in frog cells than in mammalian 
myocytes.  Biochemical  studies  have  shown  that  in  mammalian  ventricular  cells 
muscarinic  agonists  inhibit  the  effects of/3-adrenergic  agonists  on  the  adenylate 
cyclase by an indirect action of the/33~-subunits released from G proteins (G  i and/or 
Go)  (Fleming  and  Watanabe,  1988).  Consistent  with  this  hypothesis,  (a)  basal 
adenylate cyclase activity and (b) activation of this enzyme by the nonhydrolyzable 
GTP analogues could not be inhibited by muscarinic agonists. Hescheler et al. (1986) 
have shown that ACh can antagonize the activation of adenylate cyclase by/3-agonists 
via mechanisms involving GTP-binding proteins (probably Gi) and that it can inhibit 
Ca  channel  phosphorylation  and  thus  decrease  /ca.  Complementary biochemical 
evidence for this hypothesis has also been obtained (Hazeki and Ui, 1981; Endoh et 
al.,  1985;  Sorota et ai.,  1985).  In  frog atrial cells,  Breitwieser and Szabo  (1985) 
found  that  the  anti-Ckadrenergic  effect  of ACh  is  mediated  by  a  GTP-binding 
protein, and Shibata et al. (1986) have shown that GTP~'S, can inhibit the stimulatory 
effect of ISO on/ca. Our results confirm that ACh inhibits/3-adrenergic effects on 
/ca, and show that this inhibition is mediated by a GTP-binding protein, probably G i 
and/or G o, as it is in mammalian myocytes. 
These findings differ from some of the results obtained using mammalian heart 
cells  (Hescheler et al.,  1986).  In guinea pig ventricular cells the application of a 
nonhydrolyzable GTP analogue (Gpp(NH)p) increased/ca, an effect that is opposite 
to our finding. It is unlikely that it is due solely to the difference of nonhydrolyzable 
GTP analogues, since we have also observed that in rabbit ventricular cells GTP3'S 
(100-300  #M)  alone  can  increase  /ca  irreversibly  (unpublished  results).  These 
different responses to nonhydrolyzable GTP analogues could be due to differences 
between  frog  atrial  cells  and  mammalian  ventricular  myocytes  in  potency  for 
stimulation and/or inhibition of the adenylate cyclase via the stimulatory G protein 
or the inhibitory G protein. It is possible that in frog atrial cells maximal activation of 
G i  by  GTP3,S  can  overcome  the  effects  of GTP~'S  on  G s,  while  in  mammalian 
ventricular cells  this  cannot happen.  This  hypothesis is  also  compatible with  the 
observation  that  in  mammalian myocytes the  inhibitory effect of ACh  could be 
overcome by large concentrations of ISO (Hescheler et al., 1986), while in frog atrial 882  THE JOURNAL OF GENERAL PHYSIOLOGY  ￿9  VOLUME 96 ￿9 1990 
and/or ventricular cells (Fischmeister and Shrier,  1989)  this effect of ISO has not 
been observed. 
The  inhibitory  effects of ACh  on  /ca have  been  hypothesized  to  be  caused  by 
several different mechanisms: (a)  activation of a  cyclic GMP-dependent phosphodi- 
esterase (Fischmeister and Hartzell,  1987);  (b) stimulation of a  protein phosphatase 
(Watanabe  et  al.,  1984);  and/or  (c)  activation of protein kinase  C  (Shibata  et  ai., 
1986;  Lacerda et al.,  1988). All of these hypotheses require the inhibitory effects of 
ACh to be mediated by biochemical events distal  to adenylate cyclase. Our  results 
indicate  that  this  is  unlikely.  Thus,  the  application  of cAMP  increased  Ic~  in  a 
dose-dependent  manner; however, simultaneous application of ACh did not affect 
the time course of this cAMP-induced increase of/ca even when very low doses of 
cAMP  (10 -s  M)  were  used.  This  result  is  somewhat  similar  to  the  finding  of 
Fischmeister  and  Hartzell  (1986).  Furthermore,  ACh  can  block  the  effect  of 
isoproterenol on Ic~ even in the presence of the phosphodiesterase inhibitor IBMX 
(5 x  10 -4 M, results not shown).  In combination, these results suggest that the site 
of ACh action is mainly proximal to cAMP production. The role of changes in cGMP 
in  these  muscarinic  actions  of ACh  remains  unclear  (Keely  and  Lincoln,  1978; 
Shibata et al., 1986; Fischmeister and Hartzell, 1987). 
Recently it has been reported that in mammalian ventricular cells G, can directly 
activate  Ca  channels,  independendy  of cAMP  (Yatani  et  al.,  1987b;  Brown  and 
Bimbaumer,  1988;  Yatani and Brown,  1989; Pelzer et al.,  1990).  Our data suggest 
that this direct coupling may not be present in frog atrium. Thus, in our experiments 
the time course of the effect of isoproterenol on/ca is different from that of ACh on 
I~ACh), which is the best-known example of a direct effect of a G protein. In addition, 
the application of GTP'yS did not significandy increase/ca, even though IKtAC~) was 
activated  by  GTP"fS.  From  these  results  it  seems  unlikely  that  Ca  channels  are 
directly modulated by activation of G s, as is the case for the activation of G i and/or 
G o, which is involved in modulation of the ACh-dependent K + channel.  However, a 
small direct effect of G s and Ica cannot be ruled out by our whole-cell data. 
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